InspireMD (NSPR) stock price, revenue, and financials

InspireMD market cap is $4.5 m, and annual revenue was $3.60 m in FY 2018

$4.5 M

NSPR Mkt cap, 10-Jun-2019

$1.4 M

InspireMD Revenue Q2, 2019
InspireMD Gross profit (Q2, 2019)442 K
InspireMD Gross profit margin (Q2, 2019), %32.6%
InspireMD Net income (Q2, 2019)-2.2 M
InspireMD EBIT (Q2, 2019)-2.2 M
InspireMD Cash, 30-Jun-20194.8 M

InspireMD Revenue

InspireMD revenue was $3.60 m in FY, 2018

Embed Graph

InspireMD Income Statement

Annual

USDFY, 2014FY, 2015FY, 2016FY, 2017FY, 2018

Revenue

3.1m2.3m1.9m2.8m3.6m

Revenue growth, %

(26%)(18%)

Cost of goods sold

1.4m2.6m1.8m2.2m2.6m

Gross profit

1.7m(296.0k)102.0k585.0k995.0k

Gross profit Margin, %

54%(13%)5%21%28%

Sales and marketing expense

3.2m1.5m2.4m2.2m

R&D expense

3.6m1.3m1.3m1.5m

General and administrative expense

4.5m6.4m5.0m5.2m4.8m

Operating expense total

4.5m14.2m7.8m8.8m8.6m

EBIT

(8.8m)(14.5m)(7.6m)(8.2m)(7.6m)

EBIT margin, %

(284%)(627%)(404%)(298%)(211%)

Net Income

(9.3m)(15.6m)(8.5m)(8.4m)(7.2m)

Quarterly

USDQ1, 2014Q1, 2014Q2, 2014Q3, 2014Q1, 2015Q2, 2015Q3, 2015Q1, 2016Q2, 2016Q3, 2016Q1, 2017Q2, 2017Q3, 2017Q1, 2018Q2, 2018Q3, 2018Q1, 2019Q2, 2019

Revenue

1.6m1.5m193.0k273.0k477.0k685.0k632.0k563.0k540.0k469.0k569.0k640.0k718.0k1.0m1.0m769.0k415.0k1.4m

Cost of goods sold

750.0k625.0k584.0k349.0k514.0k897.0k543.0k497.0k478.0k438.0k495.0k493.0k565.0k714.0k726.0k571.0k488.0k912.0k

Gross profit

802.0k857.0k(391.0k)(76.0k)(37.0k)(212.0k)89.0k66.0k62.0k31.0k74.0k147.0k153.0k293.0k277.0k198.0k(73.0k)442.0k

Gross profit Margin, %

52%58%(203%)(28%)(8%)(31%)14%12%11%7%13%23%21%29%28%26%(18%)33%

Sales and marketing expense

830.0k1.3m1.9m1.8m995.0k401.0k329.0k532.0k632.0k671.0k492.0k580.0k605.0k634.0k620.0k

R&D expense

1.5m2.6m2.4m2.5m1.4m747.0k781.0k478.0k301.0k289.0k350.0k403.0k288.0k252.0k230.0k416.0k1.1m865.0k

General and administrative expense

2.3m2.5m2.4m2.1m2.0m1.6m1.7m1.6m1.2m1.2m1.6m1.4m1.3m1.5m940.0k1.2m1.3m1.1m

Operating expense total

4.7m6.4m6.8m6.4m3.3m3.4m2.5m2.1m1.9m1.8m2.5m2.4m2.2m2.2m1.8m2.2m3.1m2.6m

EBIT

(3.9m)(5.5m)(7.2m)(6.5m)(4.9m)(3.6m)(3.4m)(2.4m)(1.8m)(1.8m)(2.4m)(2.3m)(2.1m)(2.0m)(1.5m)(2.0m)(3.1m)(2.2m)

EBIT margin, %

(250%)(373%)(3749%)(2374%)(1025%)(522%)(540%)(424%)(333%)(377%)(422%)(358%)(290%)(194%)(147%)(257%)(754%)(161%)

Interest expense

352.0k359.0k361.0k301.0k275.0k246.0k179.0k188.0k197.0k

Pre tax profit

(3.9m)(5.9m)(7.6m)(6.8m)(5.2m)(3.9m)(3.6m)(2.6m)(2.0m)(2.0m)

Net Income

(3.9m)(6.0m)(7.6m)(6.8m)(5.2m)(3.9m)(3.6m)(2.6m)(2.0m)(2.0m)(2.6m)(2.3m)(2.1m)(2.4m)(627.0k)(2.0m)(3.2m)(2.2m)

InspireMD Balance Sheet

Annual

USDFY, 2013FY, 2014FY, 2015FY, 2016FY, 2017FY, 2018

Cash

17.5m6.3m3.3m7.5m3.7m9.4m

Accounts Receivable

95.3k

Inventories

502.3k753.0k500.0k533.0k1.1m

Current Assets

21.6m9.4m4.6m8.6m5.2m11.4m

PP&E

652.0k622.0k472.0k379.0k476.0k421.0k

Total Assets

24.0m11.5m5.8m9.4m6.1m12.3m

Accounts Payable

1.9m1.6m512.0k618.0k328.0k929.0k

Current Liabilities

6.1m8.5m6.9m4.8m2.5m2.9m

Non-Current Liabilities

9.2m5.8m1.8m587.0k624.0k605.0k

Total Liabilities

15.3m14.2m8.7m5.4m3.1m3.5m

Additional Paid-in Capital

91.0m104.6m120.0m136.0m143.1m156.4m

Retained Earnings

(82.3m)(107.4m)(123.0m)(131.9m)(140.4m)(147.6m)

Total Equity

8.6m(2.8m)4.0m2.7m8.8m

Financial Leverage

2.8 x-4.1 x2.3 x2.2 x1.4 x

InspireMD Cash Flow

Annual

USDFY, 2014FY, 2015FY, 2016FY, 2017FY, 2018

Net Income

(9.3m)(15.6m)(8.5m)(8.4m)(7.2m)

Depreciation and Amortization

110.0k241.0k191.0k178.0k152.0k

Accounts Receivable

11.0k(15.0k)

Inventories

1.2m253.0k(33.0k)

Accounts Payable

2.9m(932.0k)

Cash From Operating Activities

(6.8m)(11.6m)(7.5m)(8.1m)(7.6m)

Cash From Investing Activities

(252.0k)(23.0k)70.0k(318.0k)(44.0k)

Cash From Financing Activities

9.8m8.6m11.7m4.6m13.4m

Interest Paid

111.0k863.0k399.0k583.0k

Income Taxes Paid

13.0k6.0k

Quarterly

InspireMD Ratios

USDY, 2019

Financial Leverage

1.7 x